Anti-arrhythmic effects of taurine-magnesium coordination compound on torsades de pointes

doi:10.12047/j.cjap.5596.2018.026

Abstract

Abstract: Objective:To investigate the effect of taurine magnesium coordination compound (TMCC) on torsades de pointes (TdP) in isolated guinea pig hearts. Methods:Healthy male guinea pigs weighting 250~300 g were randomly divided into 4 groups:①TdP model group (n=7):Isolated hearts were perfused by normal K-H solution 20 minutes, then perfused by slowly activated delayed rectifier potassium current(IKs) blocker 10μmol/L Chromanol 293B under hypokalemic solution(1.8 mmol/L) to establish TdP model;②~④ TdP model + TMCC group (n=6):Isolated hearts were perfused by normal K-H solution for 20 minutes, then perfused by IKs blocker 10μmol/L Chromanol 293B under hypokalemic solution(1.8 mmol/L) for 60 minutes, at the same time TMCC which concentration was 1, 2, 4 mmol/L was administered respectively by Langendorff retrograde aortic perfusion method. Cardiac surface electrocardiogram of guinea pigs in vitro was collected and recorded by Biopac electrophysiological recorder. Incidence of TdP, transmural dispersion of repolarization (TDR), instability of QT interval were acquired from Lead Ⅱ electrocardiograph (ECG) wave forms to describe the effect of TMCC on TdP model. Datas were acquired at the time of 20 min and pre-TdP, in case there was no TdP observed, a value of 60 min was entered for calculation purpose. Results:Incidence of TdP in TdP model group was 6/7. TdP incidence could be decreased significantly by 1, 2, 4 mmol/L TMCC, and was 5/6, 1/6, 0/6 respectively. Compared with the pre-drug, Chromanol 293B under hypokalemic solution in TdP model group increased TDR(corrected) evidently(P<0.01). Compared with the pre-drug, 1, 2, 4 mmol/L TMCC in TdP model + TMCC group could decrease the increased TDR(corrected) induced by Chromanol 293B under hypokalemic solution(P>0.05). Compared with the TdP model group, 2, 4 mmol/L TMCC could evidently decrease the instability of QT interval induced by Chromanol 293B under hypokalemic solution(P<0.05). During the establishment of TdP model, P waves in more than one cardiac cycle continuously were disappeared in ECG. However, P wave could always be seen independent in ECG acquired from TdP model + TMCC group. Conclusion:TMCC can play the role against TdP through decreasing TDR and instability of QT interval, and inhibiting early after depolarization(EAD).

Key words: taurine magnesium coordination compound, guinea pig, isolated heart perfusion, torsades de pointes, transmural dispersion of repolarization, instability of QT interval

LI Yan, SUN Kai, AN Meng-yao, PAN Ying-ying, SUN Tao, YIN Yong-qiang, KANG Yi, LOU Jian-shi. Anti-arrhythmic effects of taurine-magnesium coordination compound on torsades de pointes[J]. CJAP, 2018, 34(2): 106-110.

References

[1] Cheng HC, Incardona J. Models of torsades de pointes:effe cts of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts[J]. J Pharmacol Toxicol Methods, 2009, 60(2):174-184.
[2] Hondeghem LM. Disturbances of cardiac wavelength and repolarization precede torsade de pointes and ventricular fibrillation in langendorff perfused rabbit hearts[J]. Prog Biophys Mol Biol, 2016, 121(1):3-10.
[3] Antzelevitch C. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes[J]. Heart Rhythm, 2005, 2(2 Suppl):S9-S15.
[4] 吴金春, 李文强, 常荣, 等. 起搏器术后尖端扭转型室速1例[J]. 临床心电学杂志, 2017, 26(1):54-56.
[5] Monnig G, Kobe J, Loher A, et al. Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome:a long-term follow-up[J]. Europace, 2012, 14(3):396-401.
[6] 李帆. 硫酸镁联合床边紧急心脏起搏在尖端扭转型室速中的应用[J]. 中西医结合心脑血管病杂志, 2016, 14(7):788-789.
[7] 宋日文枫. 硫酸镁治疗尖端扭转型室性心动过速31例疗效分析[J]. 临床医药文献电子杂志, 2015(32):6722-6723.
[8] Zhao L, Lou J, Wu H, et al. Effects of taurine-magnesium coordination compound on ionic channels in rat ventricular myocytes of arrhythmia induced by ouabain[J]. Biol Trace Elem Res, 2012, 147(1-3):275-284.
[9] Lerche C, Bruhova I, Lerche H, et al. Chromanol 293B binding in KCNQ1(Kv7. 1) channels involves electrostatic interactions with a potassium ion in the selectivity filter[J]. Mol Pharmacol, 2007, 71(6):1503-1511.
[10] Faggioni M, Knollmann BC. Arrhythmia protection in hypokalemia:a novel role of Ca²⁺-activated K⁺ currents in the ventricle[J]. Circulation, 2015, 132(15):1371-1373.
[11] Guo L, Dong Z, Guthrie H. Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates[J]. J Pharmacol Toxicol Methods, 2009, 60(2):130-151.
[12] 郭继鸿. 短联律间期尖端扭转性室速综合征[J]. 临床心电学杂志, 2005, 14(4):289-297.
[13] Weiss JN, Garfinkel A, Karagueuzian HS, et al. Early afterdepolarizations and cardiac arrhythmias[J]. Heart Rhythm, 2010, 7(12):1891-1899.
[14] Cranefield PF. Action potentials, afterpotentials, and arrhythmias[J]. Circ Res, 1977, 41(4):415-423.
[15] Clusin WT. Calcium and cardiac arrhythmias:DADs, EADs, and alternans[J]. Crit Rev Clin Lab Sci, 2003, 40(3):337375.
[16] 焦宏, 张勇, 王晓玲. 小鼠主动脉狭窄后不同时期心室肌细胞后除极和触发活动的变化[J]. 中国应用生理学杂志, 2014, 30(3):243-246.
[17] Van der Linde H, Van de Water A, Loots W, et al. A new method to calculate the beat-to-beat instability of QT duration in drug-induced long QT in anesthetized dogs[J]. J Pharmacol Toxicol Methods, 2005, 52(1):168-177.